Susan CPA - Marimed Chief Officer

MRMD Stock  USD 0.24  0.01  4.00%   

Insider

Susan CPA is Chief Officer of Marimed
Age 55
Phone617 795 5140
Webhttps://www.marimedinc.com

Marimed Management Efficiency

The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0303 %, meaning that it created $0.0303 on every $100 dollars invested by stockholders. Marimed's management efficiency ratios could be used to measure how well Marimed manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 448.34 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Marimed has a current ratio of 1.3, suggesting that it may not be capable to disburse its financial obligations when due. Debt can assist Marimed until it has trouble settling it off, either with new capital or with free cash flow. So, Marimed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Marimed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Marimed to invest in growth at high rates of return. When we think about Marimed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Dominic BScBarloworld Ltd ADR
57
Christopher WierengaBarloworld Ltd ADR
46
Stephen RabalaisVia Renewables
N/A
Paul KonikowskiVia Renewables
51
Barbara ClayVia Renewables
52
Fabian UfferSCOR PK
N/A
Frieder KnuplingSCOR PK
53
Tantaswa FubuBarloworld Ltd ADR
50
JeanPaul ConoscenteJacopinSCOR PK
58
Franois VarenneSCOR PK
57
Michael KuznarVia Renewables
N/A
Lex KnolBarloworld Ltd ADR
68
Emmanuel BScBarloworld Ltd ADR
54
HDip CABarloworld Ltd ADR
54
Charles MBABarloworld Ltd ADR
66
William IIIVia Renewables
58
PDBA BcomBarloworld Ltd ADR
50
Mike BarajasVia Renewables
39
Claire GallRobinsonSCOR PK
48
Litha NkombisaBarloworld Ltd ADR
56
Marc PhilippeSCOR PK
54
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people. Marimed [MRMD] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Marimed Leadership Team

Elected by the shareholders, the Marimed's board of directors comprises two types of representatives: Marimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marimed. The board's role is to monitor Marimed's management team and ensure that shareholders' interests are well served. Marimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Timothy Shaw, Chief Officer
Steve West, VP Relations
Howard Schacter, Chief Officer
Sara Gullickson, VP Marketing
Susan CPA, Chief Officer
Jon Levine, President, CoFounder
Charles Finnie, Chief Officer
Ryan Crandall, VP Officer
Robert Fireman, Chairman CoFounder
Jonathan Rider, Chief Officer

Marimed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Marimed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marimed. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Marimed OTC Stock analysis

When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Please note, there is a significant difference between Marimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Marimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.